Cargando…

HLA Variation and SARS-CoV-2 Specific Antibody Response

Differences in SARS-CoV-2-specific immune responses have been observed between individuals following natural infection or vaccination. In addition to already known factors, such as age, sex, COVID-19 severity, comorbidity, vaccination status, hybrid immunity, and duration of infection, inter-individ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolday, Dawit, Fung, Chun Yiu Jordan, Morgan, Gregory, Casalino, Selina, Frangione, Erika, Taher, Jennifer, Lerner-Ellis, Jordan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143129/ https://www.ncbi.nlm.nih.gov/pubmed/37112884 http://dx.doi.org/10.3390/v15040906

Ejemplares similares

A genetic counselling protocol for the return of genomic sequencing and serological results to COVID-19 positive patients: GENCOV Study Canada
por: Casalino, Selina, et al.
Publicado: (2021)

P357: Replication of genetic variation associated with COVID-19 clinical outcomes: The GENCOV Prospective Cohort Study
por: Wolday, Dawit, et al.
Publicado: (2023)

A comprehensive genome report for COVID-19 patients: GENCOV Study Canada
por: Frangione, Erika, et al.
Publicado: (2021)

Characterizing Risk Factors for Hospitalization and Clinical Characteristics in a Cohort of COVID-19 Patients Enrolled in the GENCOV Study
por: Morgan, Gregory, et al.
Publicado: (2023)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

eP325: Medically actionable DNA variation from the GENCOV COVID-19 Genome Sequencing Study
por: Frangione, Erika, et al.
Publicado: (2022)

eP294: Return of genome sequencing results in ostensibly healthy COVID-19 positive individuals: GENCOV Study Canada
por: Casalino, Selina, et al.
Publicado: (2022)

Chronic Immune Activation and CD4(+) T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy
por: Wolday, Dawit, et al.
Publicado: (2021)

Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort study
por: Taher, Jennifer, et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies
por: Wijtvliet, Veerle P.W.M., et al.
Publicado: (2022)

HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection
por: Augusto, Danillo G, et al.
Publicado: (2022)

Genome screening, reporting, and genetic counseling for healthy populations
por: Casalino, Selina, et al.
Publicado: (2022)

Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
por: Huang, Edmund, et al.
Publicado: (2021)

Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
por: Weidner, Lisa, et al.
Publicado: (2021)

Response to Abdelrahman M et al commentary on “Parasites Protect from Severe COVID-19. Myth or Reality?”
por: Wolday, Dawit, et al.
Publicado: (2022)

HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review
por: Abd El-Baky, Nawal, et al.
Publicado: (2023)

HLA and PF4 antibody production after adenoviral vector SARS-CoV-2 vaccination
por: Bouayad, Abdellatif
Publicado: (2021)

HLA‐dependent variation in SARS‐CoV‐2 CD8 (+) T cell cross‐reactivity with human coronaviruses
por: Buckley, Paul R., et al.
Publicado: (2022)

The roles of glycans in the SARS-CoV-2 spike protein
por: Casalino, Lorenzo, et al.
Publicado: (2022)

HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine
por: Ragone, Concetta, et al.
Publicado: (2021)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Current HLA Investigations on SARS-CoV-2 and Perspectives
por: Douillard, Venceslas, et al.
Publicado: (2021)

HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity
por: Hovhannisyan, Anahit, et al.
Publicado: (2022)

SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
por: Dada, Ashraf, et al.
Publicado: (2022)

Screening for antibodies to HLA class I in apheresis donors following Covid‐19 or SARS-CoV-2 vaccination
por: Nissen-Meyer, Lise Sofie H., et al.
Publicado: (2022)

External Quality Assessment on CD4+ T-Cell Count Using in-House Proficiency Testing Panels for CD4 Count Laboratories in Addis Ababa, Ethiopia
por: Yibalih, Natnael Kidanu, et al.
Publicado: (2019)

Evaluation of the Performance of Health Extension Workers in HIV-1/2 Screening Tests: A Comparative Cross-Sectional Study, Addis Ababa, Ethiopia
por: Gashaw, Mulatu, et al.
Publicado: (2020)

Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub–Saharan Africa: A prospective longitudinal study
por: Gebrecherkos, Teklay, et al.
Publicado: (2022)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Performance of rapid rk39 tests for the diagnosis of visceral leishmaniasis in Ethiopia: a systematic review and meta-analysis
por: Hagos, Dawit Gebreegziabiher, et al.
Publicado: (2021)

Effect of SARS-CoV-2 Infection on Anti-HLA Antibodies and De Novo DSA Incidence in Lung Transplant Recipients
por: Zajacova, A., et al.
Publicado: (2022)

The association between micronutrients and the SARS-CoV-2-specific antibodies in convalescent patients
por: Panahibakhsh, Maryam, et al.
Publicado: (2022)

Allelic variation in class I HLA determines CD8(+) T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2
por: Francis, Joshua M., et al.
Publicado: (2021)

A common allele of HLA mediates asymptomatic SARS-CoV-2 infection
por: Augusto, Danillo G., et al.
Publicado: (2022)

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection
por: Augusto, Danillo G., et al.
Publicado: (2023)

SARS-CoV-2 in patients with chronic liver disease
por: Hindson, Jordan
Publicado: (2020)

HLA repertoire of 115 UAE nationals infected with SARS-CoV-2
por: Alnaqbi, Halima, et al.
Publicado: (2022)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
por: Lin, Aifen, et al.
Publicado: (2021)

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
por: Seliger, Barbara, et al.
Publicado: (2022)

Tocilizumab (Anti-IL-6R) Suppressed TNFα Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity
por: Shin, Bong-Ha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_162kie5carbjb3g8kbjgp6cd9i